Trademark: 87390143
Status Date
Tuesday, June 25, 2019
Registration Number
5788300
Registration Date
Tuesday, June 25, 2019
Filing Date
Wednesday, March 29, 2017
Published for Opposition
Tuesday, February 20, 2018
5 Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations
44 Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals
42 Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials
The mark consists of starburst patterned logo with eight points.
Issue New Certificate to: BioNTech US Inc. (Delaware corporation) 40 Erie Street, Suite 110, Cambridge MA 02139.
Color is not claimed as a feature of the mark.
Jun 3, 2022
New Certificate Under Section 7 ¿ Processed
Jun 2, 2022
Case Assigned To Post Registration Paralegal
Jan 6, 2022
Teas Section 7 Request Received
Jun 25, 2019
Registered-Principal Register
May 21, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
May 18, 2019
Allowed Principal Register - Sou Accepted
Apr 24, 2019
Statement Of Use Processing Complete
Apr 11, 2019
Use Amendment Filed
Apr 24, 2019
Case Assigned To Intent To Use Paralegal
Apr 11, 2019
Teas Statement Of Use Received
Oct 16, 2018
Teas Change Of Correspondence Received
Oct 18, 2018
Notice Of Approval Of Extension Request E-Mailed
Oct 16, 2018
Sou Extension 1 Granted
Oct 16, 2018
Sou Extension 1 Filed
Oct 16, 2018
Teas Extension Received
Apr 17, 2018
Noa E-Mailed - Sou Required From Applicant
Feb 20, 2018
Official Gazette Publication Confirmation E-Mailed
Feb 20, 2018
Published For Opposition
Jan 31, 2018
Notification Of Notice Of Publication E-Mailed
Jan 10, 2018
Approved For Pub - Principal Register
Jan 10, 2018
Examiner's Amendment Entered
Jan 10, 2018
Notification Of Examiners Amendment E-Mailed
Jan 10, 2018
Examiners Amendment E-Mailed
Jan 10, 2018
Examiners Amendment -Written
Dec 22, 2017
Teas Change Of Correspondence Received
Dec 23, 2017
Teas/Email Correspondence Entered
Dec 22, 2017
Correspondence Received In Law Office
Dec 22, 2017
Teas Response To Office Action Received
Jun 28, 2017
Notification Of Priority Action E-Mailed
Jun 28, 2017
Priority Action E-Mailed
Jun 28, 2017
Priority Action Written
Jun 21, 2017
Assigned To Examiner
Apr 5, 2017
Notice Of Design Search Code E-Mailed
Apr 4, 2017
New Application Office Supplied Data Entered In Tram
Apr 1, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
